iodoacetic acid has been researched along with cytochrome c-t in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Choi, KJ; Jung, WH; Kim, KY; Na, YJ; Park, SB; Sung, HR | 1 |
Adam, A; Al-Salmi, FA; Altalhi, T; El-Megharbel, SM; Gobouri, AA; Hamza, RZ; Refat, MS; Saad, HA | 1 |
2 other study(ies) available for iodoacetic acid and cytochrome c-t
Article | Year |
---|---|
Carbenoxolone prevents chemical eye ischemia-reperfusion-induced cell death via 11β-hydroxysteroid dehydrogenase type 1 inhibition.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Carbenoxolone; Cell Death; Cell Survival; Cells, Cultured; Cytochromes c; Eye Injuries; Humans; Iodoacetic Acid; Protective Agents; Reactive Oxygen Species; Reperfusion Injury; Trabecular Meshwork; Tumor Necrosis Factor-alpha | 2017 |
Synthesis of
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Bone and Bones; C-Reactive Protein; COVID-19 Drug Treatment; Cytochromes c; Cytokines; Disease Models, Animal; Glutathione; Iodoacetic Acid; Lipid Peroxidation; Male; Matrix Metalloproteinases; Membrane Potential, Mitochondrial; Mitochondria; Osteoarthritis; Rats; Reactive Oxygen Species; SARS-CoV-2; Succinate Dehydrogenase | 2021 |